 Nkarta Therapeutics Inc NASDAQ: NKTX will be moving into an 88,000-square-foot facility that will not only serve as its newest headquarters but will support the research, development, and future commercial manufacturing of its cell therapy pipeline. The Company did not disclose the cost of the project. 